TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A Swedish registry study of nearly 1.46 million children found that parental autoimmune disease was associated with higher offspring risk of type 1 diabetes. The association was strongest when a parent had type 1 diabetes, but the findings do not show that parental disease causes diabetes in a child.
A Swedish study of 1,455,645 children found that having a parent with an autoimmune disease was associated with a higher risk of developing type 1 diabetes. The association was strongest when a parent had type 1 diabetes, according to research published in JAMA Pediatrics; the study identifies a link, not proof that parental illness causes the condition in children.
Children whose mothers had an autoimmune disease during pregnancy had a 57% higher estimated risk of type 1 diabetes than children whose mothers did not, based on the study’s adjusted hazard ratio of 1.57 (95% confidence interval 1.46 to 1.68). Paternal autoimmune disease before the child’s birth showed a comparable association: adjusted hazard ratio 1.51 (95% CI 1.37 to 1.67). The paternal exposure was defined as disease before childbirth, while the maternal measure covered disease during pregnancy.
The estimates were larger when a parent had type 1 diabetes. Maternal type 1 diabetes was associated with a hazard ratio of 4.51 (95% CI 3.72 to 5.48); paternal type 1 diabetes had a hazard ratio of 5.79 (95% CI 4.70 to 7.13). The researchers reported the highest risk among children whose two parents had type 1 diabetes, though the supplied report does not give a separate numerical estimate for that group.
The cohort included children born in Sweden from 2001 through 2014, followed through 2023. Median age at the end of follow-up was 15.3 years, and 51.4% were male. After the team used cousin comparisons to account for some shared familial factors, the maternal autoimmune-disease association remained statistically significant but was smaller: adjusted hazard ratio 1.27 (95% CI 1.08 to 1.50).
Who May Merit Earlier Risk Discussions
The findings add evidence that type 1 diabetes risk runs in families, including across a broader range of parental autoimmune conditions than type 1 diabetes alone. The similar overall maternal and paternal associations are consistent with shared familial susceptibility, such as inherited factors, rather than an explanation based only on exposure during pregnancy. The study does not establish which mechanisms account for the observed links.
In an accompanying editorial, Mikael Knip of Biomedicum Helsinki said children with a family history of autoimmune disease form a risk group for progression to clinical type 1 diabetes. He pointed to published consensus guidance on screening and monitoring people at risk, while noting that access and implementation can vary with available resources. The results may inform discussions between families and clinicians, but they do not by themselves establish a screening recommendation for every child whose parent has an autoimmune condition.
Benjamin Nwosu, an endocrinologist at Northwell Health Cohen Children’s Medical Center who was not involved in the research, emphasized that type 1 diabetes has a complex genetic basis. He said a parent’s diagnosis can raise a child’s risk, but inheritance is not a straightforward single-gene pattern. The findings should be understood as population-level estimates, not as a prediction that an individual child will develop diabetes.
Products Worth Considering
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Bowflex SelectTech 840 Adjustable Kettlebell
As an affiliate, we earn on qualifying purchases.
How the Swedish Cohort Was Compared
Researchers led by Xingbo Mo of Karolinska Institutet used Swedish registry records to study nearly 1.5 million births and later diagnoses of type 1 diabetes. The analysis compared offspring according to whether their mother or father had an autoimmune disease. The report says 6.1% of children had a maternal autoimmune-disease exposure before delivery.
The study also found that associations varied by condition. Paternal links were stronger for endocrine autoimmune diseases, particularly autoimmune thyroiditis, while maternal links were stronger for ankylosing spondylitis and gastrointestinal autoimmune disorders. The authors said these differences could reflect parent-specific factors or possible influences during pregnancy, but described the overall picture as multifactorial.
Nwosu noted that Sweden’s northern location may limit how directly the findings apply elsewhere, because type 1 diabetes rates differ across populations. He also highlighted the role of major histocompatibility complex class 2 genes, which he said account for an estimated 40% to 50% of risk. That estimate is his comment, not a result newly measured by this cohort study.
“A clear gradient in type 1 diabetes risk was observed according to parental type 1 diabetes status, with the highest risk among offspring with both parents affected.”
— Xingbo Mo and colleagues, the study authors
Limits on Causation and Risk Estimates
The observational study shows associations, not causation. It cannot establish whether inherited susceptibility, pregnancy-related factors, shared environment, or a combination explains the higher rates. The cousin-comparison analysis accounts for some shared familial factors, but does not remove all possible sources of bias.
The researchers said registry data did not include disease severity, autoantibody levels, disease activity during pregnancy, or medication use. Those factors could affect fetal immune development or be related to observed risk, but the study could not assess them. The supplied report also does not provide absolute risks for each exposure group, so the hazard ratios should not be read as the chance that a particular child will develop type 1 diabetes.
It is also unclear how well the estimates apply outside Sweden, or whether results would differ across healthcare systems and populations. The study does not establish which children should be screened, at what age, or how often; those questions require clinical guidance beyond these findings.
How Screening Guidance May Apply
The study does not announce a new screening program or change existing guidance. Knip’s editorial points readers to published consensus recommendations for screening and monitoring people considered at risk, while acknowledging that practice may depend on resources. Families concerned about inherited or familial risk can discuss their circumstances with a qualified health professional, who can interpret them alongside current guidance.
Further research would need to clarify how specific autoimmune diagnoses, disease activity, medications, genetic factors and pregnancy exposures relate to children’s risk. Until then, the Swedish findings offer evidence of a family-level association, but not a personal forecast or a confirmed cause.
Key Questions
What did the Swedish study find?
It found that children whose parents had autoimmune disease had higher estimated rates of type 1 diabetes. The strongest associations were reported when a parent had type 1 diabetes.
Does a parent’s autoimmune disease cause type 1 diabetes in a child?
No causal link was established. This registry study found associations and could not determine whether inherited, pregnancy-related, environmental or other factors explain them.
How much higher was the risk when a parent had type 1 diabetes?
The study reported hazard ratios of 4.51 for maternal type 1 diabetes and 5.79 for paternal type 1 diabetes. These are relative estimates, not a child’s absolute probability of developing the disease.
Does the study recommend that all children with an affected parent be screened?
The study itself did not issue a screening recommendation. An accompanying editorial referred to existing consensus guidance for people considered at risk; families should seek individualized guidance from a qualified health professional.
What important information was missing?
The registry data did not capture disease severity, autoantibody levels, disease activity during pregnancy or medication use. The researchers also could not determine how directly the estimates apply beyond Sweden.
Source: medpagetoday.com
